Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Oxyresveratrol promotes hair growth and may help treat hair loss.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Alopecia areata may be treated by targeting immune system imbalances.

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

Combining finasteride and black soybean extract better protects hair cells from damage and may treat hair loss effectively with fewer side effects.

Cyclosporine improved skin condition in dogs with sebaceous adenitis.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

A new hydrogel made from human cells improves wound healing by working with immune cells to promote repair.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Changing YBX1 protein activity affects skin stem cell function and aging.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Lupus can cause a type of hair loss that doesn't scar, due to inflammation.

BlastX helps heal uninfected wounds but doesn't improve healing in infected ones.

Arg1+ macrophages may play a role in causing alopecia areata.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Curcuma longa L. may help reduce prostate inflammation.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.